NIH-funded research R01 grant

Investigating how ceramide signaling affects healthy aging and tau-related diseases in mammals

Official title: Targeting Ceramide Signaling: Enhancing Healthy Aging and Combating Tauopathy in Mammals

Funded at University of Alabama at Birmingham · NIH-11072163 · Data updated 2026-11-12

This study is looking at how a lack of growth hormone might affect how long we live and how healthy we feel as we age, using mice to see if lowering certain fats in the body can help improve health and longevity.

More Aging research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startDecember 1, 2024
Project endNovember 30, 2029
Funding year2025
Award (this year)$753,728
NIH project number1R01AG085793-01A1
Project IDNIH-11072163 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are adults over 21 years old who may be experiencing accelerated aging or age-related health issues.

Less likely to help

Patients who are under 21 years old or do not have age-related conditions may not benefit from this research.

What this research studies

This research explores the connection between growth hormone deficiency and longevity using mouse models. It focuses on how ceramides, a type of lipid, influence various aging-related processes such as insulin resistance and inflammation. By examining the effects of reducing ceramide levels through genetic and pharmacological methods, the study aims to uncover new ways to enhance healthspan and lifespan. The findings could lead to innovative treatments that improve aging outcomes in humans.

Why it matters

Potential benefit: If successful, this research could lead to new therapies that promote healthier aging and combat age-related diseases.

How similar studies have gone: Other research has shown promising results in targeting lipid signaling pathways for improving healthspan and longevity, suggesting this approach has potential.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Sun, Liou — University of Alabama at Birmingham
  • Study coordinator: Sun, Liou

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.